News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
172,716 Results
Type
Article (13169)
Company Profile (55)
Press Release (159490)
Multimedia
Podcasts (54)
Webinars (9)
Section
Business (49767)
Career Advice (1415)
Deals (7594)
Drug Delivery (59)
Drug Development (22372)
Employer Resources (93)
FDA (4273)
Job Trends (4472)
News (83641)
Policy (7256)
Tag
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (847)
Accelerated approval (18)
Adcomms (5)
Allergies (80)
Alliances (9832)
ALS (87)
Alzheimer's disease (616)
Antibody-drug conjugate (ADC) (220)
Approvals (4524)
Artificial intelligence (360)
Autoimmune disease (121)
Automation (28)
Bankruptcy (56)
Best Places to Work (3782)
BIOSECURE Act (12)
Biosimilars (104)
Biotechnology (28)
Bladder cancer (111)
Brain cancer (29)
Breast cancer (364)
Cancer (2762)
Cardiovascular disease (213)
Career advice (1200)
Career pathing (35)
CAR-T (143)
CDC (59)
Cell therapy (408)
Cervical cancer (26)
Clinical research (21268)
Collaboration (1025)
Company closure (2)
Compensation (625)
Complete response letters (21)
COVID-19 (909)
CRISPR (55)
C-suite (514)
Cystic fibrosis (88)
Data (3530)
Decentralized trials (2)
Denatured (2)
Depression (70)
Dermatology (42)
Diabetes (226)
Diagnostics (1947)
Digital health (24)
Diversity (5)
Diversity, equity & inclusion (22)
Drug discovery (155)
Drug pricing (110)
Drug shortages (16)
Duchenne muscular dystrophy (141)
Earnings (26231)
Editorial (45)
Employer branding (10)
Employer resources (84)
Events (24169)
Executive appointments (568)
FDA (6049)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (14)
Funding (917)
Gene editing (128)
Generative AI (31)
Gene therapy (329)
GLP-1 (451)
Government (1523)
Grass and pollen (7)
Guidances (244)
Healthcare (5032)
HIV (55)
Huntington's disease (21)
IgA nephropathy (36)
Immunology and inflammation (126)
Immuno-oncology (37)
Indications (85)
Infectious disease (1084)
Inflammatory bowel disease (86)
Inflation Reduction Act (8)
Influenza (61)
Intellectual property (89)
Interviews (249)
IPO (4355)
IRA (20)
Job creations (923)
Job search strategy (982)
JPM (44)
Kidney cancer (9)
Labor market (57)
Layoffs (210)
Leadership (31)
Legal (1148)
Liver cancer (47)
Longevity (11)
Lung cancer (387)
Lymphoma (220)
Machine learning (31)
Management (34)
Manufacturing (457)
MASH (130)
Medical device (3674)
Medtech (3705)
Mergers & acquisitions (3862)
Metabolic disorders (679)
mRNA (90)
Multiple sclerosis (99)
NASH (9)
Neurodegenerative disease (206)
Neuropsychiatric disorders (44)
Neuroscience (1283)
Neurotech (1)
NextGen: Class of 2026 (2016)
Non-profit (1406)
Now hiring (13)
Obesity (306)
Opinion (194)
Ovarian cancer (88)
Pain (77)
Pancreatic cancer (116)
Parkinson's disease (137)
Partnered (16)
Patents (181)
Patient recruitment (293)
Peanut (29)
People (14399)
Pharmaceutical (14)
Pharmacy benefit managers (17)
Phase 1 (6220)
Phase 2 (8935)
Phase 3 (7909)
Pipeline (3762)
Policy (194)
Postmarket research (821)
Preclinical (2001)
Press Release (12)
Prostate cancer (167)
Psychedelics (23)
Radiopharmaceuticals (120)
Rare diseases (542)
Real estate (1532)
Recruiting (42)
Regulatory (6870)
Reports (16)
Research institute (751)
Resumes & cover letters (240)
Rett syndrome (26)
RNA editing (14)
RSV (52)
Schizophrenia (74)
Series A (169)
Series B (119)
Service/supplier (3)
Sickle cell disease (71)
Special edition (12)
Spinal muscular atrophy (55)
Sponsored (36)
Startups (1786)
Stomach cancer (3)
Supply chain (61)
Tariffs (50)
The Weekly (50)
Vaccines (536)
Venture capital (86)
Weight loss (214)
Women's health (59)
Worklife (18)
Date
Today (83)
Last 7 days (322)
Last 30 days (1263)
Last 365 days (14170)
2026 (4710)
2025 (14500)
2024 (11934)
2023 (11320)
2022 (13834)
2021 (14428)
2020 (14147)
2019 (12281)
2018 (8921)
2017 (8397)
2016 (7779)
2015 (8582)
2014 (5971)
2013 (4450)
2012 (4769)
2011 (5024)
2010 (3913)
Location
Africa (330)
Alabama (23)
Alaska (1)
Arizona (77)
Arkansas (7)
Asia (13888)
Australia (2112)
California (5884)
Canada (1225)
China (526)
Colorado (262)
Connecticut (251)
Delaware (253)
Europe (30852)
Florida (625)
Georgia (126)
Hawaii (3)
Idaho (14)
Illinois (507)
India (37)
Indiana (277)
Iowa (13)
Japan (325)
Kansas (21)
Kentucky (18)
Louisiana (19)
Maine (53)
Maryland (582)
Massachusetts (4118)
Michigan (121)
Minnesota (293)
Mississippi (2)
Missouri (70)
Montana (6)
Nebraska (7)
Nevada (68)
New Hampshire (26)
New Jersey (1512)
New Mexico (8)
New York (1455)
North Carolina (614)
North Dakota (2)
Northern California (2896)
Ohio (163)
Oklahoma (10)
Oregon (13)
Pennsylvania (951)
Puerto Rico (9)
Rhode Island (19)
South America (397)
South Carolina (16)
South Dakota (1)
Southern California (2214)
Tennessee (87)
Texas (864)
United States (19428)
Utah (92)
Vermont (1)
Virginia (153)
Washington D.C. (34)
Washington State (388)
West Virginia (4)
Wisconsin (107)
172,716 Results for "f star".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Marengo Reports Late-Breaking Initial Phase 2 Clinical Results from Invikafusp Alfa Plus TRODELVY® and Unveils Partnered Novel IPN01203/STAR0501 STAR Program in Phase 1 at AACR 2026
April 17, 2026
·
6 min read
Press Releases
Star Therapeutics Receives FDA Rare Pediatric Disease and Breakthrough Therapy Designations for VGA039 in Von Willebrand Disease Prophylaxis
April 21, 2026
·
4 min read
Press Releases
MiRus Begins Patient Enrollment in the STAR Randomized Trial of the Siegel™ Transcatheter Aortic Valve
April 8, 2026
·
4 min read
Cancer
Merck’s PD-1/VEGF data star in stacked lineup of AACR ‘26 data reveals
The Merck update, which will shed light on a $588 million bet to succeed Keytruda, is part of a roster of presentations that could shape the future of ADCs, protein degraders and KRAS-targeted therapies.
April 17, 2026
·
5 min read
·
Nick Paul Taylor
Press Releases
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG
March 9, 2026
·
2 min read
Press Releases
Myosin Therapeutics Awarded Florida Cancer Innovation Fund Grant to Support STAR-GBM Clinical Trial
March 25, 2026
·
2 min read
Press Releases
Sydnexis Announces New Data from Phase 3 STAR Trial of SYD-101 Presented at 2026 AAPOS Annual Meeting
March 23, 2026
·
6 min read
Press Releases
Lantern Pharma and Starlight Therapeutics Announce FDA Clearance of IND for a Planned Phase 1 Pediatric CNS Cancer Trial of STAR-001
March 27, 2026
·
12 min read
Press Releases
Verismo Therapeutics’ Initial Clinical Data from STAR-101 Phase 1 Trial of SynKIR™-110 KIR-CAR Presented at AACR 2026 Plenary Session
April 21, 2026
·
6 min read
Press Releases
Starton Therapeutics Announces Dosing of First Patient in Phase 2a Study Evaluating STAR-LLD for the Treatment of Multiple Myeloma
February 19, 2026
·
5 min read
1 of 17,272
Next
